Filed: 2/17/2026ACC: 0001757283-26-000007
📋 What this filing means
ANDERA PARTNERS filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $176.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$176.61M
Total AUM (reported)
7.93M
Total Shares
Allocation by class
SHS$67.36M38.1%
COM$57.77M32.7%
COM SHS$32.48M18.4%
SPONSORED ADS$10.54M6.0%
ADS$8.45M4.8%
Portfolio Concentration
Top 3$157.62M89.2%
4–10$18.99M10.8%
Top 3 weight
89.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.93M
Sole
Full voting authority
7.93M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
KESTRA MED TECHNOLOGIES LTD
SOLEShares2.54M
TypeSH
Market value$67.36M
38.14%
Sole
2.54M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares1.59M
TypeSH
Market value$57.77M
32.71%
Sole
1.59M
Shared
0.00
None
0.00
EVOMMUNE INC
SOLEShares1.90M
TypeSH
Market value$32.48M
18.39%
Sole
1.90M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares78.13K
TypeSH
Market value$10.54M
5.97%
Sole
78.13K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares1.82M
TypeSH
Market value$8.45M
4.79%
Sole
1.82M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KESTRA MED TECHNOLOGIES LTDSOLE | SHS | 2.54M | SH | $67.36M 38.14% | 2.54M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 1.59M | SH | $57.77M 32.71% | 1.59M | 0.00 | 0.00 |
EVOMMUNE INCSOLE | COM SHS | 1.90M | SH | $32.48M 18.39% | 1.90M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 78.13K | SH | $10.54M 5.97% | 78.13K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 1.82M | SH | $8.45M 4.79% | 1.82M | 0.00 | 0.00 |